Marché des canules nasales à haut débit en Asie-Pacifique jusqu’en 2027 – Analyse régionale et prévisions par composant (mélangeur d’oxygène de l’air, canule nasale, circuit inspiratoire chauffé et humidificateur actif) ; Application (bronchectasie, insuffisance respiratoire aiguë, insuffisance cardiaque aiguë et maladie pulmonaire obstructive chronique) ; Utilisateur final (centres de soins ambulatoires, hôpitaux et centres de soins de longue durée) et pays
Le marché des canules nasales à haut débit en Asie-Pacifique devrait
atteindre 2 536,52 millions de dollars américains en 2027, contre 951,53 millions de dollars américains en 2018. Le marché devrait croître avec un TCAC de 11,7 % entre 2019 et 2027.
Les facteurs clés qui stimulent la croissance du marché des canules nasales à haut débit sont la population âgée croissante et l’augmentation des maladies respiratoires chroniques dans la région APAC. Cependant, les facteurs qui freinent la croissance du marché sont les séquelles associées aux canules nasales à haut débit.
Selon la NCD Alliance, les problèmes respiratoires chroniques Les maladies (CRD) décrivent une série de maladies des voies respiratoires et des autres structures des poumons. L\'asthme et les allergies respiratoires, les maladies pulmonaires professionnelles, la maladie pulmonaire obstructive chronique (MPOC), le syndrome d\'apnée du sommeil et l\'hypertension pulmonaire en sont quelques-uns. Le fardeau des maladies respiratoires chroniques (MRC) augmente dans tous les pays d’Asie-Pacifique. Selon l\'article publié dans The Lancet Global Health, l\'Inde compte 18 % de la population mondiale et un fardeau croissant de maladies respiratoires chroniques.
La prévalence de l\'asthme en Inde est significativement élevée par rapport à d\'autres pays. Avec environ 15 à 20 millions de patients asthmatiques, au moins un patient asthmatique sur dix vit en Inde. Selon les estimations de l\'OMS, environ 30 millions d\'Indiens souffrent d\'asthme. Certains des facteurs courants expliquant l\'augmentation du nombre de cas d\'asthme en Inde comprennent l\'obésité, le tabagisme, la pollution de l\'air intérieur et extérieur, la surutilisation ou la mauvaise utilisation soudaine d\'antibiotiques, le pollen, la fumée secondaire, les maisons et les lieux de travail mal ventilés, entre autres. . Outre l\'asthme, l\'augmentation des cas de BPCO est un sujet de préoccupation dans le pays. Selon l\'étude Global Burden of Disease de l\'Université de Washington, 2018, la BPCO était la deuxième cause de décès en Inde, entraînant la mort de près de 958 000 personnes.
< /p>
Revenus et prévisions du marché indien des canules nasales à haut débit jusqu\'en 2027 (en millions de dollars américains)
Marché européen des canules nasales à haut débit - Par composant
Mélangeur d\'oxygène à air
Canule nasale
Circuit inspiratoire chauffé
Humidificateur actif
Europe à haut débit Marché des canules nasales - Par application
Bronchectasie
Insuffisance respiratoire aiguë
< li>Insuffisance cardiaque aiguë
Maladie pulmonaire obstructive chronique (MPOC)
Marché européen des canules nasales à haut débit - Par utilisateur final
Strategic insights for Asia-Pacific High-Flow Nasal Cannula involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
The regional scope of Asia-Pacific High-Flow Nasal Cannula refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - Asia-Pacific High-Flow Nasal Cannula Market
The List of Companies - APAC High Flow Nasal Cannula Market
Great Group Medical Co., Ltd.
Salter Labs
Fisher And Paykel Healthcare Limited
TNI Medical Ag
Mek-Ics Co., Ltd.
Flexicare Medical Limited
Vapotherm
Teleflex Incorporated
Resmed
Hamilton Medical Inc,
Frequently Asked Questions
How big is the Asia-Pacific High-Flow Nasal Cannula Market?
The Asia-Pacific High-Flow Nasal Cannula Market is valued at US$ 951.53 Million in 2018, it is projected to reach US$ 2,536.52 Million by 2027.
What is the CAGR for Asia-Pacific High-Flow Nasal Cannula Market by (2019 - 2027)?
As per our report Asia-Pacific High-Flow Nasal Cannula Market, the market size is valued at US$ 951.53 Million in 2018, projecting it to reach US$ 2,536.52 Million by 2027. This translates to a CAGR of approximately 11.7% during the forecast period.
What segments are covered in this report?
The Asia-Pacific High-Flow Nasal Cannula Market report typically cover these key segments-
Utilisateur final (centres de soins ambulatoires, hôpitaux et centres de soins de longue durée)
What is the historic period, base year, and forecast period taken for Asia-Pacific High-Flow Nasal Cannula Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia-Pacific High-Flow Nasal Cannula Market report:
Historic Period : 2016-2017
Base Year : 2018
Forecast Period : 2019-2027
Who are the major players in Asia-Pacific High-Flow Nasal Cannula Market?
The Asia-Pacific High-Flow Nasal Cannula Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Great Group Medical Co., Ltd.
Salter Labs
Fisher And Paykel Healthcare Limited
TNI Medical Ag
Mek-Ics Co., Ltd.
Flexicare Medical Limited
Vapotherm
Teleflex Incorporated
Resmed
Hamilton Medical Inc,
Who should buy this report?
The Asia-Pacific High-Flow Nasal Cannula Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Asia-Pacific High-Flow Nasal Cannula Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Asia-Pacific High-Flow Nasal Cannula Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines
Get Free Sample For Asia-Pacific High-Flow Nasal Cannula Market
